I-Mab (NASDAQ:IMAB) finished Friday with a subtraction of -$0.01 to close at $2.54, a downside of -0.39 percent. An average of 387,420 shares of common stock have been traded in the last five days. There was a fall of -$0.15 in the past week, and it reached a new high 2 times over the past 12 months. The last 20 days have seen an average of 346,575 shares traded, while the 50-day average volume stands at 315,758.
IMAB stock has decreased by -11.50% in the last month. The company shares reached their 1-month lowest point of $2.44 on 08/11/23. With the stock rallying to its 52-week high on 01/17/23, shares of the company touched a low of $2.44 and a high of $8.44 in 52 weeks. It has reached a new high 6 times so far this year and lost -39.23% or -$1.64 in price. In spite of this, the price is down -69.90% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
I-Mab (IMAB) stock’s beta is 0.95. Other valuation ratios to consider include the price-to-book (PB) ratio at 0.52.
Financial Health
The quick ratio of I-Mab for the recent quarter was 4.80, and the current ratio was 4.80, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.01 for the recent quarter. Its gross profit as reported stood at -$36.07 million compared to revenue of -$32.12 million.
Earnings Surprise
For the recent quarter, I-Mab had $34.13 million in cash. The company posted a net income of -$363.53 million in the quarter, while revenues were shrunk -0.64%.
Technical Picture
From a technical analysis perspective, let’s take a brief look at I-Mab (IMAB) price momentum. RSI 9-day as of the close on 11 August was 34.79%, suggesting the stock is Neutral, with historical volatility in this time frame at 31.82%.
As of today, IMAB’s price is $2.55 -5.58% or -$0.15 from its 5-day moving average. IMAB is currently trading -8.96% lower than its 20-day SMA and -28.65% lower than its 100-day SMA. However, the stock’s current price level is -18.06% below the SMA50 and -27.94% below the SMA200.
The stochastic %K and %D were 18.06% and 14.12%, respectively, and the average true range (ATR) was 0.15. With the 14-day stochastic at 16.73% and the average true range at 0.16, the RSI (14) stands at 37.81%. The stock has reached -0.08 on the 9-day MACD Oscillator while the 14-day reading was at -0.16.
Analyst Ratings
Siebert Williams Shank launched coverage on I-Mab (NASDAQ: IMAB) in its analyst report released on December 09, 2021. The firm assigned the stock a Buy rating. The consensus rating for I-Mab (IMAB) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell IMAB, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 4 others rate it as a “buy”.
What is IMAB’s price target for the next 12 months?
Analysts predict a range of price targets between $8.00 and $25.00, with a median target of $24.50. Taking a look at these predictions, the average price target given by analysts for I-Mab (IMAB) stock is $20.50.
